-
Symbol
-
STRO on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value
-
Latest Disclosed Shares Owned
-
2,092,281 shares
-
Security Ownership %
-
2.5%
Shares, Excluding Options vs Price
BlackRock, Inc. ownership in Sutro Biopharma, Inc. Common Stock, $0.001 par value (STRO)
16 Jul 2025 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,092,281 shares of Sutro Biopharma, Inc. Common Stock, $0.001 par value (STRO).
This represents 2.5% ownership of the company.
In their previous filing dated 17 Apr 2025, BlackRock, Inc. had reported owning 6,143,608 shares, indicating a decrease of +66%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.